UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rational design, synthesis and biological evaluation of novel HIV-1 protease inhibitors containing 2-phenylacetamide derivatives as P2 ligands with potent activity against DRV-Resistant HIV-1 variants

Bioorganic & medicinal chemistry letters, 2024-03, Vol.101, p.129651-129651, Article 129651

2024

Volltextzugriff (PDF)

Molecular Docking, Synthesis and anti-HIV-1 Protease Activity of Novel Chalcones

Current pharmaceutical design, 2020-01, Vol.26 (8), p.802-814

2020

Volltextzugriff (PDF)

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors

Molecules (Basel, Switzerland), 2023-08, Vol.28 (17), p.6330

2023

Volltextzugriff (PDF)

Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch

Biomolecules (Basel, Switzerland), 2021-03, Vol.11 (4), p.489

2021

Volltextzugriff (PDF)

Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods

Chemometrics and intelligent laboratory systems, 2020-01, Vol.196, p.103888, Article 103888

2020

Volltextzugriff (PDF)

Development of A Fission Yeast Cell-Based Platform for High Throughput Screening of HIV-1 Protease Inhibitors

Current HIV research, 2019-01, Vol.17 (6), p.429-440

2019

Volltextzugriff (PDF)

An enzymatic route to the synthesis of tricyclic fused hexahydrofuranofuran P2-Ligand for a series of highly potent HIV-1 protease inhibitors

Tetrahedron letters, 2024-04, Vol.140, p.155013, Article 155013

2024

Volltextzugriff (PDF)

Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy

AIDS (London), 1999-11, Vol.13 (16), p.2261-2267

1999

Volltextzugriff (PDF)

Overcoming drug resistance in HIV‐1 chemotherapy: The binding thermodynamics of Amprenavir and TMC‐126 to wild‐type and drug‐resistant mutants of the HIV‐1 protease

Protein science, 2002-08, Vol.11 (8), p.1908-1916

2002

Volltextzugriff (PDF)

The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release

Journal of virology, 2022-05, Vol.96 (9), p.e0219821-e0219821

2022

Volltextzugriff (PDF)

Cover Feature: Probing the Interaction between HIV‐1 Protease and the Homodimeric p66/p66’ Reverse Transcriptase Precursor by Double Electron‐Electron Resonance EPR Spectroscopy (ChemBioChem 21/2020)

Chembiochem : a European journal of chemical biology, 2020-11, Vol.21 (21), p.2998-2998

2020

Volltextzugriff (PDF)

Nanopore detects γ-radiation inhibited HIV-1 protease activity

Biosensors & bioelectronics, 2021-12, Vol.194, p.113602-113602, Article 113602

2021

Volltextzugriff (PDF)

Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I

Biochemical and biophysical research communications, 2019-06, Vol.514 (3), p.974-978

2019

Volltextzugriff (PDF)

Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes

Acta crystallographica. Section D, Biological crystallography., 2010-03, Vol.66 (3), p.233-242

2010

Volltextzugriff (PDF)

Development of a triazole-linked bis-organosilane compound as dual-function agent: Sensing of Al3+ ion in aqueous environments and inhibition of HIV-1 protease

Journal of molecular structure, 2025-01, Vol.1319, p.139572, Article 139572

2025

Volltextzugriff (PDF)

Insights into the structural function of the complex of HIV-1 protease with TMC-126: molecular dynamics simulations and free-energy calculations

Journal of molecular modeling, 2012-05, Vol.18 (5), p.1841-1854

2012

Volltextzugriff (PDF)

Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants

European journal of medicinal chemistry, 2020-01, Vol.185, p.111866-111866, Article 111866

2020

Volltextzugriff (PDF)

Sulfonamide inhibitors: a patent review 2013-present

Expert opinion on therapeutic patents, 2018-07, Vol.28 (7), p.541-549

2018

Volltextzugriff (PDF)

HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues

European journal of medicinal chemistry, 2023-09, Vol.257 (C), p.115501-115501, Article 115501

2023

Volltextzugriff (PDF)

Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants

ChemMedChem, 2018-04, Vol.13 (8), p.803-815

2018

Volltextzugriff (PDF)

Thermodynamic dissection of the binding energetics of KNI-272, a potent HIV-1 protease inhibitor

Protein science, 2000-09, Vol.9 (9), p.1801-1809

2000

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C

European journal of medicinal chemistry, 2022-04, Vol.233, p.114251-114251, Article 114251

2022

Volltextzugriff (PDF)

Anti-HIV/SIV activity of icariin and its metabolite anhydroicaritin mainly involve reverse transcriptase

European journal of pharmacology, 2020-10, Vol.884, p.173327-173327, Article 173327

2020

Volltextzugriff (PDF)

Premature Activation of the HIV-1 Protease Is Influenced by Polymorphisms in the Hinge Region

Viruses, 2024-05, Vol.16 (6), p.849

2024

Volltextzugriff (PDF)

HIV-1 Infection Induces Interleukin-1β Production via TLR8 Protein-dependent and NLRP3 Inflammasome Mechanisms in Human Monocytes

The Journal of biological chemistry, 2014-08, Vol.289 (31), p.21716-21726

2014

Volltextzugriff (PDF)

1 – 25 von 6.384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.970)
Mit Volltextzugriff
(5.115)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.350)
Humans
(5.005)
Life Sciences & Biomedicine
(4.798)
Hiv Infections - Drug Therapy
(2.992)
Hiv-1 - Drug Effects
(2.650)
Infectious Diseases
(2.418)
Biological And Medical Sciences
(2.400)
Hiv-1 - Genetics
(2.220)
Aids/hiv
(2.211)
Medical Sciences
(2.117)
Male
(2.089)
Female
(2.016)
Hiv Infections - Virology
(2.013)
Virology
(1.897)
Hiv
(1.888)
Human Immunodeficiency Virus
(1.848)
Human Immunodeficiency Virus 1
(1.831)
Adult
(1.816)
Hiv Protease Inhibitors - Therapeutic Use
(1.636)
Hiv-1
(1.628)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.924)
EZB Electronic Journals Library
(3.185)
IngentaConnect
(3.116)
Journals@Ovid
(2.434)
IngentaConnect Journals
(1.842)
Single Journals
(1.415)
ScienceDirect Journals (5 years ago - present)
(1.039)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(874)
Wiley Blackwell Single Titles
(683)
Wiley Online Library Full Collection 2018
(576)
Oxford Journals Online Current
(404)
Springer Nature - Complete Springer Journals
(399)
Oxford Journals 2020 Medicine
(373)
JSTOR
(317)
SAGE Complete A-Z List
(246)
Taylor & Francis Journals Auto-Holdings Collection
(242)
Taylor & Francis Current Content Access
(232)
Taylor & Francis:Master (3349 titles)
(214)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(181)
Nexis Uni
(100)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(507)
Aids Research And Human Retroviruses
(297)
Plos One
(253)
Journal Of Acquired Immune Deficiency Syndromes
(227)
Journal Of Virology
(191)
Antimicrobial Agents And Chemotherapy
(171)
Antiviral Therapy
(157)
Journal Of Medicinal Chemistry
(139)
The Journal Of Infectious Diseases
(123)
Hiv Medicine
(119)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Rational design, synthesis and biological evaluation of novel HIV-1 protease inhibitors containing 2-phenylacetamide derivatives as P2 ligands with potent activity against DRV-Resistant HIV-1 variants

Molecular Docking, Synthesis and anti-HIV-1 Protease Activity of Novel Chalcones

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors

Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch

Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods

Development of A Fission Yeast Cell-Based Platform for High Throughput Screening of HIV-1 Protease Inhibitors

An enzymatic route to the synthesis of tricyclic fused hexahydrofuranofuran P2-Ligand for a series of highly potent HIV-1 protease inhibitors

Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy

Overcoming drug resistance in HIV‐1 chemotherapy: The binding thermodynamics of Amprenavir and TMC‐126 to wild‐type and drug‐resistant mutants of the HIV‐1 protease

The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release

Cover Feature: Probing the Interaction between HIV‐1 Protease and the Homodimeric p66/p66’ Reverse Transcriptase Precursor by Double Electron‐Electron Resonance EPR Spectroscopy (ChemBioChem 21/2020)

Nanopore detects γ-radiation inhibited HIV-1 protease activity

Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I

Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes

Development of a triazole-linked bis-organosilane compound as dual-function agent: Sensing of Al3+ ion in aqueous environments and inhibition of HIV-1 protease

Insights into the structural function of the complex of HIV-1 protease with TMC-126: molecular dynamics simulations and free-energy calculations

Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants

Sulfonamide inhibitors: a patent review 2013-present

HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues

Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants

Thermodynamic dissection of the binding energetics of KNI-272, a potent HIV-1 protease inhibitor

Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C

Anti-HIV/SIV activity of icariin and its metabolite anhydroicaritin mainly involve reverse transcriptase

Premature Activation of the HIV-1 Protease Is Influenced by Polymorphisms in the Hinge Region

HIV-1 Infection Induces Interleukin-1β Production via TLR8 Protein-dependent and NLRP3 Inflammasome Mechanisms in Human Monocytes

Suchergebnisse filtern